12 Followers on Owler

Kleo

Kleo is a biotechnology company that develops and commercializes therapeutics for the treatment of cancer and infectious diseases. Read more

KLEO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Kite Pharma is seen as one of Kleo's top competitors. Kite Pharma was founded in 2009, and is headquartered in Santa Monica, California. Like Kleo, Kite Pharma also competes in the Biotechnology industry. Kite Pharma generates $42M more revenue vs. Kleo.

Inovio is a top competitor of Kleo. Inovio was founded in 1979, and its headquarters is in Plymouth Meeting, Pennsylvania. Like Kleo, Inovio also competes in the Pharmaceuticals field. Inovio has 242 more employees than Kleo.

bluebird bio is Kleo's #3 rival. bluebird bio was founded in Cambridge, Massachusetts} in 1992. Like Kleo, bluebird bio also works within the Biotechnology industry. Compared to Kleo, bluebird bio generates $238.7M more revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 20 a good estimate for Kleo's Employee count?

Kleo Acquisitions

No recent acquisitions found related to Kleo

Kleo Funding History

Since Kleo was founded in 2015, it has participated in 4 rounds of funding. In total Kleo has raised $59.1M. Kleo's last funding round was on Jul 2020 for a total of $5.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Grant
Jul 2020
$5M

Bill & Melinda Gates Foundation

Equity
Feb 2020
$19.4M
-
Equity
Nov 2018
$21.2M
-
Series A
Aug 2016
$13.5M

Since Kleo was founded in 2015, it has participated in 4 rounds of funding. In total Kleo has raised $59.1M. Kleo's last funding round was on Jul 2020 for a total of $5.0M

Kleo Investments

No recent investments found related to Kleo

Kleo News

September 21, 2020Benzinga

Kleo Pharmaceuticals to Present at "Bioscience Pipeline & Innovation in Connecticut in the Age of COVID" Conference

NEW HAVEN, Conn., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Kleo Pharmaceuticals, Inc., a targeted immunothe... See more »
July 13, 2020Philanthropy News Digest

Gates Foundation awards $5 million for COVID-19 therapeutics research

The grant to Kleo Pharmaceuticals will support efforts to advance development of a COVID-19 hyperimmu... See more »
July 8, 2020MarketScreener

Kleo Pharmaceuticals Announces $5 Million Grant to Advance Development of COVID-19 Hyperimmune Globulin Mimic (HGM) as a Therapeutic for Infected Patients

(marketscreener.com) NEW HAVEN, Conn., July 08, 2020 -- Kleo Pharmaceuticals, a leading company in th... See more »
June 2, 2020Benzinga

Kleo Pharmaceuticals to Present Corporate Overview and Pipeline Update at Jefferies Virtual Healthcare Conference

NEW HAVEN, Conn., June 01, 2020 (GLOBE NEWSWIRE) -- Kleo Pharmaceuticals, Inc., a leading company in ... See more »
May 21, 2020MarketScreener

Kleo Pharmaceuticals and Celularity Enter into Research Collaboration to Rapidly Develop Allogeneic NK Cell Combination Therapies for COVID-19 and Multiple Myeloma

(marketscreener.com) NEW HAVEN, Conn., May 21, 2020 -- Kleo Pharmaceuticals, Inc., a leading company ... See more »
March 31, 2020Medical Buyer

Kleo Pharmaceuticals Enters Into Research Collaboration With Green Cross LabCell (GCLC) To Rapidly Develop COVID-19-Targeting Allogeneic NK Cell Combination Therapy

Kleo Pharmaceuticals Inc., a leading company in the field of developing next-generation, fully synthe... See more »

Kleo Press Releases

April 9, 2020StreetInsider

Biohaven Receives FDA May Proceed Letter to Begin Phase 2 Trial of Intranasal Vazegepant to Treat Lung Inflammation After COVID-19 Infection

NEW HAVEN, Conn., April 9, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: B... See more »
February 6, 2020centralcharts

Kleo Pharmaceuticals Receives IND Authorization to Proceed from FDA for its Multiple Myeloma Therapeutic

Kleo Pharmaceuticals Receives IND Authorization to Proceed from FDA for its Multiple Myeloma Therapeu... See more »
December 2, 2019StreetInsider

Kleo Pharmaceuticals to Present at Piper Jaffray 31st Annual Healthcare Conference

NEW HAVEN, Conn., Dec. 2, 2019 /PRNewswire/ -- Kleo...... See more »
October 15, 2019PR Newswire

Kleo Pharmaceuticals to Present at 2019 BIO Investor Forum

NEW HAVEN, Conn., Oct. 15, 2019 /PRNewswire/ -- Kleo Pharmaceuticals Inc., a unique immuno-oncology c... See more »
August 8, 2019StreetInsider

Kleo Pharmaceuticals Announces Open-House Event To Celebrate Innovator of the Month Award

NEW HAVEN, Conn., Aug. 8, 2019 /PRNewswire/ --Â Kleo...... See more »
May 16, 2019PR Newswire

Kleo Pharmaceuticals to Present at Two Upcoming Industry Conferences

NEW HAVEN, Conn., May 16, 2019 /PRNewswire/ -- Kleo Pharmaceuticals Inc., a unique immuno-oncology co... See more »
February 26, 2019PR Newswire

Kleo Pharmaceuticals to Present at the 2019 BIO Asia International Conference

NEW HAVEN, Conn., Feb. 26, 2019 /PRNewswire/ -- Kleo Pharmaceuticals Inc., a unique immuno-oncology c... See more »

Social Media

Kleo Headquarters

150 Munson Street 25 Science Park Suite 2D

New Haven, Connecticut06511

Driving Directions »

Trending Companies

Kleo Summary

ABOUT

Overview

Kleo is a biotechnology company that develops and commercializes therapeutics for the treatment of cancer and infectious diseases. Kleo was founded in 2015. Kleo's headquarters is located in New Haven, Connecticut, USA 06511. It has raised 59.1M in 4 ...

CEO

Kleo's CEO, Douglas J. Manion, currently has an approval rating of 87%. Kleo's primary competitors are Kite Pharma, Inovio & bluebird bio.

Frequently Asked Questions about Kleo

  1. When was Kleo founded?

    Kleo was founded in 2015
  2. Who is Kleo's CEO?

    Kleo's CEO is Douglas J. Manion
  3. How much revenue does Kleo generate?

    Kleo generates $3M in revenue
  4. How much funding does Kleo have?

    Kleo has historically raised $59.1M in funding
  1. Where is Kleo's headquarters?

    Kleo's headquarters is in New Haven Connecticut, USA
  2. How many employees does Kleo have?

    Kleo has 20 employees
  3. What sector does Kleo operate in?

    Kleo is in Pharmaceuticals, Biotechnology
  4. Who are Kleo's competitors?

    Kleo's top competitors are Kite Pharma, Inovio, bluebird bio